Skip to search formSkip to main contentSkip to account menu

daniplestim

A synthetic cytokine and interleukin-3 (IL-3) receptor agonist with enhanced hematopoietic potency. Daniplestim exhibits 10- to 20-fold greater… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The availability of several enhancement techniques has made it possible to study delivery of macromolecules through skin. This… 
2001
2001
Modified and chimeric cytokines have been developed to aid in the recovery of hematopoietic precursor cells after myeloablative… 
2000
2000
PURPOSE To evaluate the safety and hematopoietic activity of daniplestim administered concurrently with granulocyte colony… 
2000
2000
BACKGROUND Supplementation of PBPC autografts with ex vivo expanded PBMC may significantly reduce or eliminate the period of… 
1999
1999
We investigated the effects of administering a high-affinity interleukin-3 receptor agonist (daniplestim) and granulocyte colony… 
1999
1999
The refolding of daniplestim, a human interleukin‐3 variant (SC‐55494) from Escherichia coli inclusion bodies, was optimized… 
1998
1998
This study evaluated the ability of daniplestim, a high affinity interleukin 3 receptor agonist, to enhance the hematopoietic…